|
FY2025
7 months to Dec 31, 2025
|
|
|---|---|
| Net income | |
| Interest income on Trust Account | |
| Change on fair value of over-allotment option liability | |
| Share based compensation expense | |
| Prepaid expenses | |
| Accounts payable | |
| Accrued expenses | |
| Net cash used in operating activities | |
| Investment in Trust Account | |
| Net cash used in investing activities | |
| Proceeds from sale of Units | |
| Proceeds from sale of Private Placement Units | |
| Payment of underwriter fees and commissions | |
| Proceeds from issuance of Class B ordinary shares | |
| Proceeds from promissory note – related party | |
| Payment of promissory note – related party | |
| Payment of offering costs | |
| Net cash provided by financing activities | |
| Net change in cash and cash equivalents | |
| Cash and cash equivalents – end of period | |
| Supplemental disclosure of non-cash investing and financing activities: | |
| Deferred offering costs within accrued offering costs |
Loading...
